• Publications
    Expected Returns Articles
  • Research
    Companies Funds Top 40 My Studies
  • Stock Screen
    New Stock Screen Manage Screens
  • Dashboards
    My Dashboards New Dashboard
  • Forum
  • Events
  • Search
  • Contact Us
  • Sign In

Stryker (SYK)

Company Ticker Sector | Industry Quality PAR
Stryker SYK Healthcare | Medical Devices 98 7.3%
Current Price ( 6/13 4:00PM EDT) $377.30
Projected Return on Value (PROVE) 5.9%
Relative Momentum 53.6
Expected Income Statement
Current Sales 23,218.0
Sales Growth Forecast 8.8%
Net Profit Margin 22.2%
Projected Shares Outstanding 378.37
EPS - Five year Forecast $20.80
Average P/E Ratio 24.7
Projected Average Price $513.68
Price Appreciation (Annualized) 6.4%
Annual Dividend Yield 0.9%
Projected Annual Return 7.3%
Quality
Financial Strength 96 24.1
EPS Stability 99 24.7
Industry Sales Growth Rate 11.5% 9.6
Industry Net Profit Margin 15.5% 17.9
Calculated Quality Rating 81.3
Fundamental Data Updated: 05/09/2025
MIPAR 9.8%  
Sweet Spot 14.8% - 19.8%  
Top In Medical Devices
Ticker Quality PAR
LNTH 80 16.8%
BRKR 72 21.2%
BSX 95 11.5%
GMED 84 13.6%
ZBH 90 11.9%
Top In Healthcare
Ticker Quality PAR
UTHR 92 21.9%
HALO 77 20.1%
COO 89 15.5%
SLP 84 16.6%
UFPT 93 14.2%

© 2006 - 2025 Manifest Investing. All rights reserved.
About | Terms of Service | Disclaimer | Privacy Policy

Legend
Quality Legend:
Blue Excellent with quality greater than 80.
Green Good with quality between 60 and 80.
Neutral Average or below average with quality between 20 and 60.
Red Poor with quality less than 20.
Companies with less than 10 years of history are penalized by 5 points per year.
PAR Legend:
Green PAR is within the target range of MIPAR +5-10%, currently 5.1%-10.1%
Yellow PAR is above the target range of MIPAR +10%, currently 10.1%
PAR Projected Annual Return
MIPAR The Manifest Investing Median PAR of all stocks in the database.
Company Name Legend:
* Not covered by Value Line Standard Edition.
b Uses price-to-book value for valuation purposes.
P/CF Uses price-to-cash flow for valuation.